Abstract | BACKGROUND: OBJECTIVE: DESIGN: An open randomized, controlled, multicenter trial, powered for equivalence. SETTING: 60 oncology centers in 10 countries. PATIENTS: INTERVENTION: MEASUREMENTS: RESULTS: For itraconazole and amphotericin B, the median duration of therapy was 8.5 and 7 days and the median time to defervescence was 7 and 6 days, respectively. The intention-to-treat efficacy analysis of data from 360 patients showed response rates of 47% and 38% for itraconazole and amphotericin B, respectively (difference, 9.0 percentage points [95% CI, -0.8 to 19.5 percentage points]). Fewer drug-related adverse events occurred in the itraconazole group than the amphotericin B group (5% vs. 54% of patients; P = 0.001), and the rate of withdrawal because of toxicity was significantly lower with itraconazole (19% vs. 38%; P = 0.001). Significantly more amphotericin B recipients had nephrotoxicity (P < 0.001). Breakthrough fungal infections (5 patients in each group) and mortality rates (19 deaths in the itraconazole group and 25 deaths in the amphotericin B group) were similar. Sixty-five patients switched to oral itraconazole solution after receiving the intravenous formulation for a median of 9 days. CONCLUSIONS:
|
Authors | M Boogaerts, D J Winston, E J Bow, G Garber, A C Reboli, A P Schwarer, N Novitzky, A Boehme, E Chwetzoff, K De Beule, Itraconazole Neutropenia Study Group |
Journal | Annals of internal medicine
(Ann Intern Med)
Vol. 135
Issue 6
Pg. 412-22
(Sep 18 2001)
ISSN: 0003-4819 [Print] United States |
PMID | 11560454
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Antifungal Agents
- Antineoplastic Agents
- Drug Combinations
- Deoxycholic Acid
- Itraconazole
- Amphotericin B
- amphotericin B, deoxycholate drug combination
|
Topics |
- Administration, Oral
- Amphotericin B
(administration & dosage, adverse effects)
- Anti-Bacterial Agents
(therapeutic use)
- Antifungal Agents
(administration & dosage, adverse effects)
- Antineoplastic Agents
(adverse effects)
- Deoxycholic Acid
(administration & dosage, adverse effects)
- Drug Combinations
- Fever
(etiology)
- Humans
- Infusions, Intravenous
- Itraconazole
(administration & dosage, adverse effects)
- Mycoses
(complications, drug therapy)
- Neoplasms
(complications, drug therapy)
- Neutropenia
(immunology)
- Opportunistic Infections
(complications, drug therapy)
- Risk Factors
- Treatment Failure
|